The Centre for Amyloidosis and Acute Phase Proteins comprises the NHS National Amyloidosis Centre, funded by the Department of Health, to provide diagnostic and management advisory services for the national caseload of patients with amyloidosis and hereditary periodic fever syndromes, and the Wolfson Drug Discovery Unit. These teams undertake world leading, wide ranging, basic and clinical research on amyloid and amyloidosis, C‑reactive protein and serum amyloid a protein, leading to design and development of new treatments.

The Centre conducts world leading research in all aspects of the pentraxin family of plasma proteins, and in amyloidosis. Studies range from molecular, genetic, biochemical, physiological and pathological investigations to clinical diagnostics, patient management and new drug discovery. There are extensive collaborative links with scientists, clinicians and industry in many of these areas.

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM

Rheumatology:
Prof. Philip Hawkins, FMedSci